Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (1108)

Company Market Cap Price
CLPT ClearPoint Neuro, Inc.
ClearPoint's core offerings include neurosurgical navigation hardware and related surgical equipment (e.g., ClearPoint system, Prism Laser Therapy, Velocity Alpha drill).
$490.37M
$17.51
-7.84%
KOPN Kopin Corporation
CR3 medical headset and defense medical imaging/biometric sensing align with Medical Devices & Biometrics.
$490.02M
$3.04
-6.88%
VREX Varex Imaging Corporation
Core Medical Imaging category representing imaging hardware and components used in medical devices.
$489.70M
$11.85
-1.58%
ANGO AngioDynamics, Inc.
Core product category: vascular intervention devices, including Auryon, AlphaVac, and AngioVac.
$485.17M
$11.93
+0.80%
VPG Vishay Precision Group, Inc.
Medical infusion pump design win indicates participation in the Medical Devices & Biometrics market.
$473.15M
$35.74
-5.97%
LAB Standard BioTools Inc.
SomaScan laboratory testing and advisory services are a core direct offering.
$451.99M
$1.19
-4.03%
KIDS OrthoPediatrics Corp.
Directly manufactures pediatric orthopedic implants and devices (plates, screws, growing rods, braces), the core product category for the company.
$415.72M
$16.54
+0.79%
AUNA Auna S.A.
AUNA operates hospitals and provides inpatient and outpatient care, i.e., hospital services.
$413.20M
$5.67
+1.34%
TMCI Treace Medical Concepts, Inc.
Treace's core bunion correction systems are surgical instruments/devices used in operative procedures.
$410.14M
$6.50
-1.37%
SRDX Surmodics, Inc.
Surmodics' vascular intervention devices (SurVeil DCB, Pounce thrombectomy, Sublime radial access) are a core product category sold by the company.
$404.96M
$27.51
-2.86%
MLAB Mesa Laboratories, Inc.
Clinical Genomics hardware (MassARRAY) is diagnostic equipment used in regulated lab environments, fitting Diagnostic Equipment.
$402.28M
$73.65
+0.14%
CBLL CeriBell, Inc.
Ceribell's core product is a point-of-care diagnostic EEG system (diagnostic equipment).
$394.68M
$10.91
-3.79%
MTLS Materialise N.V.
Materialise's Mimics platform centers on medical imaging analysis and planning workflows.
$389.84M
$6.37
-3.48%
AHG Akso Health Group
Sale of medical devices and biometrics hardware.
$381.33M
$1.60
RXST RxSight, Inc.
RxSight's core offering is the Light Adjustable Lens system and related ophthalmic devices used in premium cataract surgery, which fits Ophthalmology Devices.
$365.73M
$9.01
+3.80%
SY So-Young International Inc.
Wuhan Miracle Laser integration indicates the company uses/markets medical devices and biometrics in aesthetics.
$357.71M
$3.52
+1.44%
DDD 3D Systems Corporation
Offers dental equipment and dental 3D printing solutions (NextDent).
$357.40M
$2.63
-4.53%
QSI Quantum-Si incorporated
The company manufactures diagnostic-grade hardware instruments (Platinum/Proteus) used for proteomics analysis.
$337.64M
$1.85
-7.50%
SOPH SOPHiA GENETICS S.A.
Liquid Biopsy: MSK-ACCESS application and liquid biopsy analytics integrated into the platform.
$332.19M
$4.70
-6.00%
MPAA Motorcar Parts of America, Inc.
MPAA markets and sells diagnostic equipment, such as the JBT-1 Bench Top tester.
$331.77M
$17.05
-1.30%
NVEC NVE Corporation
Medical devices & biometrics applications, including implantable sensors and collaboration with Abbott.
$327.19M
$66.29
-2.00%
DCTH Delcath Systems, Inc.
The company sells medical device technology (hepatic delivery system) and related procedures.
$316.22M
$9.40
-1.26%
NPCE NeuroPace, Inc.
Core product Neuromodulation device (RNS System) delivering brain-responsive, on-demand therapy for drug-resistant epilepsy.
$308.31M
$9.40
MG Mistras Group, Inc.
MG provides Laboratory Testing & Advisory Services as part of its inspection and testing offerings.
$299.83M
$9.61
+0.21%
SCPH scPharmaceuticals Inc.
Auto-Injector Devices reflect the SCP-111 autoinjector program for at-home administration.
$299.33M
$5.67
SPOK Spok Holdings, Inc.
GenA alphanumeric pager represents a medical device hardware line under Medical Devices & Biometrics.
$283.54M
$13.79
-0.90%
SMLR Semler Scientific, Inc.
QuantaFlo is a diagnostic device used to measure arterial blood flow for PAD, directly constituting Diagnostic Equipment.
$283.36M
$23.98
-5.63%
BWAY BrainsWay Ltd.
Core product: BrainsWay's Deep TMS neuromodulation devices.
$277.74M
$16.77
-3.51%
CERS Cerus Corporation
Cerus' INTERCEPT Blood System is a medical device platform; primary product is a device used in transfusion safety.
$277.18M
$1.47
-3.62%
DBVT DBV Technologies S.A.
Viaskin patch is a medical device delivering therapy; categorize under Medical Devices & Biometrics.
$275.03M
$14.32
+0.49%
TKNO Alpha Teknova, Inc.
Teknova is the exclusive US/Canada manufacturer and distributor of the PluriFreeze PF10 cryopreservation system, a medical device.
$271.48M
$4.74
-6.79%
OMI Owens & Minor, Inc.
OMI sells and distributes medical devices and biometric equipment for home healthcare and clinical use.
$269.58M
$3.48
+1.01%
SGHT Sight Sciences, Inc.
Directly manufactures ophthalmic surgical devices (OMNI Surgical System, TearCare-related tools) used in eye care, i.e., ophthalmology devices.
$263.68M
$4.99
-2.25%
CVRX CVRx, Inc.
CVRx's Barostim is a neuromodulation device (implantable) that modulates the autonomic nervous system via baroreflex activation for heart failure.
$260.47M
$10.00
-3.47%
LFCR Lifecore Biomedical, Inc.
New 5-head aseptic isolator filler expands capacity for filling into prefilled syringes.
$251.03M
$6.78
-4.64%
SMTI Sanara MedTech Inc.
bone fusion/orthopedic implants (BiFORM, ALLOCYTE Plus) and associated bone void filler (OsStic) place the company in Orthopedic Devices.
$250.82M
$28.12
-3.00%
MGRM Monogram Orthopaedics, Inc.
Direct product category: Monogram's system is a surgical device used in operating rooms for orthopedic procedures.
$243.79M
$6.00
SNWV SANUWAVE Health, Inc.
SANUWAVE directly manufactures and markets medical devices (UltraMIST and related wound-care technology) and biometrics for patient care.
$235.28M
$27.47
+0.18%
STXS Stereotaxis, Inc.
Catheter-based cardiology devices (ablation/catheters) are a core direct product, fitting Cardiology Devices.
$232.20M
$2.72
-2.16%
HUMA Humacyte, Inc.
Humacyte's Symvess is a vascular conduit/endovascular device used for extremity vascular trauma—fits Vascular Intervention Devices.
$226.47M
$1.46
-8.18%
← Previous
1 ... 4 5 6 7 8 ... 12
Next →
Showing page 6 of 12 (1108 total stocks)

Loading company comparison...

Loading research report...

AUNA Auna S.A.

Auna S.A. Prices $365 Million 8.750% Senior Secured Notes Due 2032

Nov 04, 2025
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS Reports Q3 2025 Earnings: Revenue $19.5 M, Net Loss $20 M, 31 New Customers

Nov 04, 2025
AUNA Auna S.A.

Auna S.A. Announces Private Placement of Senior Secured Notes Due 2032, Plans Tender Offer for 2029 Notes

Oct 28, 2025
LFCR Lifecore Biomedical, Inc.

Lifecore Biomedical and PolyPeptide Laboratories Announce End‑to‑End Peptide Manufacturing Collaboration

Oct 28, 2025
BWAY BrainsWay Ltd.

BrainsWay Expands Strategic Investments with New Minority Stakes in U.S. Mental Health Providers

Oct 27, 2025
SGHT Sight Sciences, Inc.

Sight Sciences Secures Medicare Fee Schedule for TearCare Procedure

Oct 17, 2025
HUMA Humacyte, Inc.

Humacyte Announces $60 Million Oversubscribed Registered Direct Offering

Oct 07, 2025
CLPT ClearPoint Neuro, Inc.

ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide

Oct 06, 2025
SOPH SOPHiA GENETICS S.A.

Myriad Genetics and SOPHiA GENETICS Partner to Develop Global Liquid Biopsy Companion Diagnostic

Sep 23, 2025
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS and AstraZeneca Expand Collaboration to Enhance Breast and Prostate Cancer Detection

Sep 22, 2025
BWAY BrainsWay Ltd.

BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for MDD Treatment

Sep 16, 2025
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS Partners with Jessa Ziekenhuis to Unify NGS Workflows and Advance Precision Oncology in Belgium

Sep 05, 2025
BWAY BrainsWay Ltd.

BrainsWay Makes Strategic Investment in Neurolief Ltd., Targeting At-Home MDD Therapy Market

Aug 21, 2025
BWAY BrainsWay Ltd.

BrainsWay Invests in Axis Integrated Mental Health to Expand Deep TMS Access

Aug 20, 2025
BWAY BrainsWay Ltd.

BrainsWay Reports Record Q2 2025 Revenue and Raises Full-Year Guidance

Aug 13, 2025
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS Reports Strong Q2 2025 Results, Announces Largest Contract in Company History

Aug 05, 2025
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS Expands Partnership with Result Laboratorium for Scalable Pharmacogenomics Insights

Jun 30, 2025
BWAY BrainsWay Ltd.

BrainsWay Reports Positive Results from Accelerated Deep TMS Study for Major Depressive Disorder

Jun 11, 2025
BWAY BrainsWay Ltd.

BrainsWay Makes $5 Million Strategic Minority-Stake Investment in Stella MSO, LLC

Jun 04, 2025
BWAY BrainsWay Ltd.

BrainsWay Reports Record Q1 2025 Sales and Significant Profit Growth, Reaffirms Full-Year Guidance

May 13, 2025
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS Reports Strong First Quarter 2025 Results with 13% Revenue Growth and Record Gross Margin

May 06, 2025
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS Expands AstraZeneca Collaboration to Accelerate Global Liquid Biopsy Testing

Apr 28, 2025
SOPH SOPHiA GENETICS S.A.

Precision for Medicine Partners with SOPHiA GENETICS to Enhance Biopharma Services with AI-Driven Platform

Apr 08, 2025
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS Reaches Two Million Patient Genomic Profiles Analyzed on AI Platform

Mar 18, 2025
BWAY BrainsWay Ltd.

BrainsWay Achieves Record Q4 and Full Year 2024 Sales, Provides Strong 2025 Guidance

Mar 11, 2025
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS CEO to Present at NVIDIA GTC AI Conference

Mar 06, 2025
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS Reports Q4 and Full Year 2024 Results, Provides 2025 Outlook

Mar 04, 2025
SOPH SOPHiA GENETICS S.A.

Leading Institutions Globally Adopt SOPHiA GENETICS' MSK-ACCESS® for Liquid Biopsy Testing

Feb 24, 2025
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS Achieves ISO 27017 and ISO 27018 Certifications for Cloud Security

Jan 09, 2025
BWAY BrainsWay Ltd.

BrainsWay Reports Positive Pilot Data for Accelerated Deep TMS in Alcohol Use Disorder, Secures NIH Funding

Dec 12, 2024
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS Launches MSK-IMPACT® for Global Solid Tumor Profiling

Nov 21, 2024
BWAY BrainsWay Ltd.

BrainsWay Deep TMS Shows Promising Feasibility Data for Neuropathic Pain Reduction

Nov 20, 2024
BWAY BrainsWay Ltd.

BrainsWay Reports Strong Q3 2024 Financial Results and Raises Full-Year Guidance

Nov 12, 2024
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS Expands Partnership with Genomenon to Streamline Genetic Research

Nov 06, 2024
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS Reports Third Quarter 2024 Results Amidst Clinical Growth and Improved Cash Burn

Nov 05, 2024

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks